Compare CNTN & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNTN | MPV |
|---|---|---|
| Founded | 2017 | 1988 |
| Country | United States | United States |
| Employees | 3 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.2M | 201.1M |
| IPO Year | 2022 | N/A |
| Metric | CNTN | MPV |
|---|---|---|
| Price | $3.41 | $18.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 533.9K | 10.2K |
| Earning Date | 02-23-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.71% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.71 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.03 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.46 | $15.65 |
| 52 Week High | $5.27 | $21.00 |
| Indicator | CNTN | MPV |
|---|---|---|
| Relative Strength Index (RSI) | 24.60 | 47.85 |
| Support Level | N/A | $18.21 |
| Resistance Level | $4.78 | $19.49 |
| Average True Range (ATR) | 0.34 | 0.39 |
| MACD | -0.13 | -0.00 |
| Stochastic Oscillator | 10.63 | 55.61 |
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.